• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮拮抗剂。2. 新型7α-(乙酰硫基)-15,16-亚甲基螺内酯

Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones.

作者信息

Nickisch K, Bittler D, Laurent H, Losert W, Casals-Stenzel J, Nishino Y, Schillinger E, Wiechert R

出版信息

J Med Chem. 1987 Aug;30(8):1403-9. doi: 10.1021/jm00391a023.

DOI:10.1021/jm00391a023
PMID:3612688
Abstract

Some 15,16-methylene derivatives of the aldosterone antagonist spironolactone were synthesized with the purpose of increasing the antialdosterone potency and reducing the endocrinological effects of this standard compound. By introduction of a 1,2-double bond and a 15 beta,16 beta-methylene ring in the spironolactone molecule both goals were achieved. In animal studies mespirenone exhibited a threefold-greater antialdosterone potency and less than 10% of the antiandrogenic activity of spironolactone.

摘要

为提高醛固酮拮抗剂螺内酯的抗醛固酮效力并降低该标准化合物的内分泌效应,合成了约15种15,16-亚甲基衍生物。通过在螺内酯分子中引入1,2-双键和15β,16β-亚甲基环,两个目标均得以实现。在动物研究中,美螺酮的抗醛固酮效力提高了两倍,且抗雄激素活性不到螺内酯的10%。

相似文献

1
Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones.醛固酮拮抗剂。2. 新型7α-(乙酰硫基)-15,16-亚甲基螺内酯
J Med Chem. 1987 Aug;30(8):1403-9. doi: 10.1021/jm00391a023.
2
Aldosterone antagonists. 3. Synthesis and activities of steroidal 7 alpha-(alkoxycarbonyl)-15,16-methylene spirolactones.醛固酮拮抗剂。3. 甾体7α-(烷氧羰基)-15,16-亚甲基螺内酯的合成与活性
J Med Chem. 1990 Feb;33(2):509-13. doi: 10.1021/jm00164a007.
3
Aldosterone antagonists. 4. Synthesis and activities of steroidal 6,6-ethylene-15,16-methylene 17-spirolactones.醛固酮拮抗剂。4. 甾体6,6-亚乙基-15,16-亚甲基-17-螺内酯的合成与活性
J Med Chem. 1991 Aug;34(8):2464-8. doi: 10.1021/jm00112a022.
4
Aldosterone antagonists. 1. Synthesis and activities of 6 beta,7 beta:15 beta,16 beta-dimethylene steroidal spirolactones.醛固酮拮抗剂。1. 6β,7β:15β,16β-二亚甲基甾体螺内酯的合成与活性
J Med Chem. 1985 May;28(5):546-50. doi: 10.1021/jm50001a002.
5
Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives.醛固酮拮抗剂。2. 11,12-脱氢孕烷衍生物的合成及生物活性
J Med Chem. 1987 Sep;30(9):1647-58. doi: 10.1021/jm00392a022.
6
Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.美螺内酯及其他15,16-亚甲基-17-螺内酯,一类新型甾体醛固酮拮抗剂。
Arzneimittelforschung. 1986 Nov;36(11):1583-600.
7
Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
J Pharmacol Exp Ther. 1987 Feb;240(2):650-6.
8
Experimental studies on the endocrine side effects of new aldosterone antagonists.
Arzneimittelforschung. 1988 Dec;38(12):1800-5.
9
Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.新型甾体类醛固酮拮抗剂的构效关系。体外对盐皮质激素受体的亲和力与体内抗醛固酮活性的比较。
Biochem Pharmacol. 1983 May 1;32(9):1479-85. doi: 10.1016/0006-2952(83)90469-0.
10
The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
Arzneimittelforschung. 1984;34(3):241-6.

引用本文的文献

1
Corticosteroid receptor antagonists: a current perspective.皮质类固醇受体拮抗剂:当前视角
Pharm World Sci. 1995 Mar 24;17(2):31-41. doi: 10.1007/BF01875052.